Bruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis
Author:
Affiliation:
1. Neuroimmunology Unit, Department of Neuroscience, Hospital Alemán, Buenos Aires, Argentina
2. Department of Neurology, Fleni, Buenos Aires, Argentina
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728214.2020.1822817
Reference36 articles.
1. Multiple Sclerosis
2. Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
3. Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis
4. Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
5. Kinase inhibitors: the road ahead
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of ibrutinib on inflammation in a mouse model of Graves’ orbitopathy;Frontiers in Endocrinology;2024-08-30
2. Unraveling the Role of the Glycogen Synthase Kinase-3β, Bruton’s Tyrosine Kinase, and Sphingosine 1 Phosphate Pathways in Multiple Sclerosis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08
3. Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment;Archives of Pharmacal Research;2024-07
4. Bruton's tyrosine kinase ablation inhibits B cell responses and antibody production for the prevention of chronic rejection in cardiac transplantation;Clinical Immunology;2024-04
5. Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations;Current Opinion in Neurology;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3